Skip to main content
PLOS One logoLink to PLOS One
. 2022 Dec 22;17(12):e0277387. doi: 10.1371/journal.pone.0277387

A novel histopathological classification of implant periapical lesion: A systematic review and treatment decision tree

Jiaming Gong 1,2,#, Ruimin Zhao 1,#, Zhanhai Yu 3, Jianxue Li 1, Mei Mei 1,*
Editor: Fahad Umer4
PMCID: PMC9778521  PMID: 36548276

Abstract

Background

Implant periapical lesion (IPL), as a peri-implant disease originating from implant apex, maintains coronal osseointegration in the early stage. With the understanding to IPL increasingly deepened, IPL classification based on different elements was proposed although there still lacks an overall classification system. This study, aiming to systematically integrate the available data published in the literature on IPL associated with histopathology, proposed a comprehensive classification framework and treatment decision tree for IPL.

Methods and findings

English articles on the topic of “implant periapical lesion”, “retrograde peri-implantitis” and “apical peri-implantitis” were searched on PubMed, Embase and Web of Science from 1992 to 2021, and citation retrieval was performed for critical articles. Definite histopathology and radiology of IPL are indispensable criteria for including the article in the literature. The protocol was registered in PROSPERO (CRD42022378001). A total of 509 papers identified, 28 studies were included in this review. In only one retrospective study, 37 of 39 IPL were reported to be at the inflammatory or abscess stage. 27 cases (37 implants) were reported, including acute non-suppurative (1/37, developed to chronic granuloma), chronic granuloma (5/37), acute suppurated (2/37), chronic suppurated-fistulized (6/37), implant periapical cyst (21/37), poor bone healing (2/37), foreign body reaction (1/37). Antibiotics alone did not appear to be effective, and the consequence of surgical debridement required cautious interpretation because of the heterogeneity of lesion course and operation. Implant apicoectomy and marsupialization were predictable approaches in some cases.

Conclusions

The diversiform nature of IPL in the case reports confirms the need for such histopathological classification, which may enhance the comparison and management of different category.

Introduction

Intraoral implants, possessing the advantage of not affecting the integrity of adjacent teeth and the esthetic properties, have frequently been adopted to complete dentition defects since the concept of osseointegration was put forward [1]. Inevitable implant-related complications have also emerged with implant periapical lesion (IPL) first described as an independent disease entity by McAllister et al in 1992 [2]. Compared to the progression and the affected portion of periimplantitis [3], IPL, originating at the implant tip, maintained normal coronal bone in the early stage.

Previous studies briefly classified IPL as active or inactive in accordance with signs and symptoms [4, 5]. Understandably, active IPL had a tendency to expand and spread proximally, coronally or facially, with localized pain, mucosal swelling, and fistulas. Different etiologies were proposed to play a part in active IPL such as bone overheating during osteotomy, residual infection of the implant bed, and adjacent endodontic lesion [4, 5]. Correspondingly, several terms were used to describe these phenomena, including retrograde periimplantitis, apical periimplantitis and endodontic periimplantitis. Moreover, there also appeared inactive IPL when radiographic manifestations were not relevant to clinical symptoms [4, 5]. The overpreparation of implant bed and the placement of the implant around scar tissue were generally considered to be induced causes.

Of concern was the appearance of a cyst at the implant tip. From the case reports [68], implantation may stimulate epithelial residual or inflammatory transformation to formulate cyst at the implant tip, which might cause localized pain, mucosal swelling, and implant mobility. Radiologically, it was indistinguishable from the previously enumerated IPL types. The previously proposed classifications [4, 5, 911] (Table 1) omitted implant periapical cyst, which is surprising for the symptom that potentially causes implant failure.

Table 1. The present classification systems regarding the IPL.

Author Category Definition
Reiser & Nevins Inactive (non- infected) Apical scar, overdrilling
Active (infected) Residual infection or contaminated implant
Sussman Implant to Tooth Osteotomy preparation causes adjacent tooth pulp devitalization
Tooth to Implant Adjacent tooth periapical pathology or previously existing apical lesion
Sarmast et al Class1, 2 same as Sussman Same as Sussman
Improper placement or angulation of the implant Implants that are placed too far labially or lingually/palatially
Residual infection Residual bacteria/viruses and/or necrotic bone/subclinical infection or placement into an infected or inflamed sinus
Penarrocha-Diago et al. Inactive Asymptomatic Apical scar caused by overpreparation or by bone necroses due to overheating
Active Acute non-suppurated Acute, spontaneous, continuous pain
Mucosa can be swelled and reddish
No peri-implant alterations
Acute suppurated Implant periapical radiolucency
others same as non-suppurated
subacute or suppurated-fistulized Dull pain; Periapical radiolucent area
Possible fistulous tract or abscess or implant mobility
Kadkhodazadeh & Amid Primary periodontal lesions (P-class) P1: apical peri-implantitis
P2: marginal peri-implantitis
P3: marginal and apical peri-implantitis
Primary Implant complications (I-class) I1: apical periodontitis
I2: marginal periodontitis
I3: marginal and apical periodontitis
Periodontal and peri-implant lesions S1: apical lesions
S2: marginal lesions
S3: marginal and apical lesions
Traumatic lesions with an iatrogenic origin T0: non symptomatic
T1: symptomatic lesions
Shah et al. Mild <25% of the implant length from apex
Moderate 25–50% of the implant length from apex
Advanced >50% of the implant length from apex

At present, there is a lack of a feasible, comprehensive method to both classify and report all conditions present in implant periapical area. At the end, we proposed a novel classification, in which corresponding treatment decision tree was designed to assess its capability to comprise ever-increasing complexity of manifestation and management. Through a systematic review of the literature evidence, the purpose of this study was to use progressively detailed categories as indicators to describe the multiformity of IPL, explicating latent pathogenesis and treatment protocols.

Materials and methods

Protocol

This systematic review complied with the PRISMA statement and its protocol was registered in PROSPERO (CRD42022378001).

Focus question

The specific research question was: “What histopathological characteristics are associated with IPL?”

Literature searching

The research was performed in accordance with Cochrane Collaboration recommendations, and it included all published articles related to IPL from 1992 to 2021 on PubMed, Embase and Web of Science. Keywords "retrograde peri-implantitis", "apical peri-implantitis", "implant periapical lesion" were searched in the title/abstract, and citation retrieval was performed for critical articles.

Eligibility criteria

Participants had a history of dental implants. The affected implants needed to be diagnosed as IPL by radiography and histopathology. The results involved radiography, histopathology, and implant outcome. Reviews, conference papers, protocols, non-English publications, and lack of sufficient evidence were excluded.

Studies selection and data extraction

The studies were independently assessed by two reviewers (Wang and Dai) and disagreements were resolved through discussion. Meanwhile, two reviewers independently extracted the information from the literature according to a preset table, which was then further checked by a third reviewer (ZRM). Domains of extraction included author, number of patients, implant site, follow-up, clinical description, histopathology (extracted verbatim), category, interventions, and outcomes.

Quality assessment

All case series reports were assessed via modified The Joanna Briggs Institute (JBI) Critical Assessment Checklist (https://synthesismanual.jbi.global.) and the processes were conducted independently by two reviewers (WJ and DZM). The study was assessed as low risk if it provided more than 75% of the required parameters; And parameters of 50% to 75% were assessed as medium risk; Parameter being less than 50% was classified as high risk.

Information synthesis

The included cases were reviewed for histopathology for the internal integration. Descriptive analysis was used for all extracted information.

Result

Searching results

509 literatures were preliminarily searched, and 28 literatures were finally evaluated after eliminating the reduplicative and substandard literatures. (Fig 1).

Fig 1. PRISMA flowchart.

Fig 1

Characteristics of the included articles

Table 2 showed the information of IPL extracted after retrieval. There were 27 case reports [68, 1234] and 1 retrospective study [35], all of which were conducted in humans. The following signs and symptoms were frequently mentioned in the case reports: swelling, abscess, localized pain, and fistula. Radiographically, all cases clearly showed radiography in the implant tip, with osseointegration remaining in the implant crown.

Table 2. The characteristics of IPL studies with histological evidence.

Author Patient Implant site Follow-up Clinical description Histopathology (verbatim extracts) Category Interventions Outcomes
Swelling Pain Abscess Fistula Mobility Radiolucency Non-surgery Surgery
Balshi et al. 2007 Case 39 Maxilla (9 anterior, 8 posterior); mandible (11 anterior, 11 posterior) Average of 1.64 years Only 66.7% (26 of 39) demonstrated clinical evidence of infection (eg, swelling, suppuration, fistula formation). - 39+ …a stroma of delicate bundles of immature collagen fibers interspersed by active fibrocytes and numerous dilated capillaries. Throughout the stroma an infiltrate of inflammatory cells, predominantly lymphocytes and plasma cells, was reported. Not sure - Apicoectomy and GBR One failure; 38 success
Casado et al. 2008 Case one 11 3 years - - - - - + In the cyst wall a dense lymphocytic infiltrate, veins, and peripheral nerves… Implant periapical cyst - Organic bovine matrix graft Success
Chan et al. 2011 Case two 41 3 months - - - - - + …fibrous connective tissue with a mild chronic mixed inflammatory cell infiltrate…clusters of inflammatory cells, primarily lymphocytes, were noted in a background of relatively dense connective tissue. Poor bone healing - Bone graft (allograft) Success
24 1 month + - - - - + … numerous acute and chronic inflammatory cells could be seen in a background of immature granulation tissue containing numerous small to medium-diameter blood vessels… Chronic Granuloma RCT of adjacent tooth GBR with cortical bone allograft and bioabsorable membrane Success
Chaffee et al. 2001 Case one 46 35 days - - + - - + …the presence of granulation tissue containing acute inflammatory cells, necrotic debris, and abundant hemorrhage bound by fibrous connective tissue infiltrated with chronic inflammatory cells. Chronic suppurated-fistulized RCT of adjacent tooth GBR with DFDBA and barrier Success
Dahlin et al. 2008 Case one 43 2 years + + - + - + Granulation tissue… revealed a periapical inflammatory infection around the top of the implant. Chronic suppurated-fistulized - Apicoectomy Success
Favia et al. 2011 Case one 36 4 months - - + - - + …a gap was observed between bone and implant. This bone was nonvital, and many osteocyte lacunae were empty… . No newly formed bone or osteoblasts… No osteoclasts or Howship lacunae… to see a connective tissue with an inflammatory cell infiltrate Chronic suppurated-fistulized - Debridgement Failure
37 4 months - - + - - + …bone trabeculae were observed within the apical implant threads… Osteoid matrix was present in many portions; no osteoblasts…a loose connective tissue with many spindle cells, plasma cells, and many inflammatory cells… Chronic suppurated-fistulized - Debridgement Failure
Galzignato et al. 2010 Case one 12 3 months - - - - - + … a residual odontogenic inflammatory cyst, characterised by a thick, irregular, often incomplete, squamous epithelium, with granulation tissue forming the cyst wall in the denuded areas. The fibrous capsule… Implant periapical cyst - Remove cyst Failure
Kochaji et al. 2017 case one 46 6 months - - - - - + … a layer of inconspicuous nonkeratinized stratified squamous epithelium lying on an inflamed fibrous tissue wall with a dense capsule-like outerlayer. The epithelial nature of the lining cells was confirmed… a radicular or apical inflammatory dental cyst around the apex of a tooth. Implant periapical cyst - Remove cyst Failure
case one 46 9 months - - - - - + … a cyst wall with the lumen lined by hyperplastic non-keratinized epithelium of several cell layers thickness supported by immature and mature fibrous tissue… a radicular cyst. Implant periapical cyst - Remove cyst Failure
Kim et al. 2013 Case one 15,16,17 10 years + - - - - + … a pseudostratified ciliated columnar epithelium and a partly stratified squamous epithelium. There were some inflammatory cells in the cyst wall. A pathologic diagnosis of a POMC was made. Implant periapical cyst - Remove cyst and bone graft (xenograft and autogenous cortical bone) Success
Manfro et al. 2018 Case one 21 1 year - + - - - + … The implant was not osseointegrated in the chronically infected apical alveolar bone. Chronic Granuloma Antibiotics -cephalexin Debridgement (EDTA, Ethylene Diamine Tetraacetic Acid), apicoectomy and bone graft (alloplastic biphasic calcium phosphate material) Success
Mccracken et al. 2012 Case one 42 2 years - - - - - + The biopsy was read as a periapical granulma with generalized chronic and acute inflammation, with associated vital reactive bony spicules. Chronic Granuloma - Debridgement Success
Mccrea et al. 2014 Case one 21 3 years - - - - - + The fibrous wall was lined by thin, stratified squamous epithelium and partly by pseudostratified columnar epithelium and cuboidal epithelium. A few nerve bundles and blood vessels were also present in the wall. Implant periapical cyst - Remove cyst and GBR with allograft, Bio-Oss and Bio-gide Success
Nedir et al. 2007 Case one 15 3.5 years + + + + - + The starch distribution in the tissue was not homogeneous; starch particles seemed to agglomerate. Foreign body reaction Amoxicillin presurgury Apicoectomy Sucesss
Piattelli et al. 1995 Case one 14 2 months + + + - - + … small colonies of bacteria around the outer perimeter of the implant.…tissue that stained with basic fuchsin inside the hole in the apical part of the implant Acute suppurated Antibiotic partially resolution FDDMA membrane Failure
Piattelli et al. 1998 (1) Case one 14 7 months - - - - - + … necrotic bone was observed inside the antirotational hole; all of the osteocyte lacunae were empty.… The bone trabeculae appeared to be compressed, and some of them had undergone demineralization… All other parts of the implant surface were surrounded by vital, compact, mature bone. Poor bone healing Metronidazole Debridgement Failure
Piattelli et al. 1998 (2) Case one Premolar of right mandible 5 months + + - + - + … bone and intiammotory tissue with an absence ot vasculor structures. The infiammotory cell infiltróte…showed a prevaience ot mocrophages and iymphocytes, with piasma ceils and granulocytes … Chronic suppurated-fistulized Metronidazole Debridgement Failure
Park et al. 2004 Case one 15,17 13 years + - - - - + … as POMC. Some cilia were observed, but ciliary loss due to chronic inflammation was also evident. The cystic lesion was lined with pseudostratified columnar epithelial cells … Implant periapical cyst - Remove cyst One failure; one success
Pistilli et al. 2020 Case three 12 4 years + + - - - + The histopathologic report described the lesion as a cyst measuring 7*5 millimeters. Implant periapical cyst - Remove cyst, apicoectomy and GBR Success
36 1 year - + - - - + The histopathologic report described the lesion as a cyst measuring 8*5 mm. Implant periapical cyst - Remove cyst and GBR Success
47 Not report + + - - - + The histopathologic report described the lesion as a cyst measuring 15*9 mm. Implant periapical cyst - Remove cyst and GBR Success
Qu et al. 2013 Case one 46 5 months - - - - - + … inflammatory cyst wall-like lesion, with the infiltration of macrophage and lymphocytes, but the epithelial lining was undetected. Implant periapical cyst - Cyst removal Success
Scarano et al. 2000 Case one Premolar in right mandible 6 months - + - - - + …bone and non mineralized tissues were present only in the most apical portion of the implant……necrotic and almost completely demineralized bone was present; some multinucleated cells … Chronic Granuloma - Debridgement Failure
Silva et al. 2010 Case one 21 1 year + - - - - + The lesion and implant were completely removed, and histological examination confirmed the diagnosis of periapical inflammatory cyst. Implant periapical cyst - Remove cyst Failure
Sun et al. 2013 Case one 35 2.5 years - + + - - + … 2 sulfur granules demonstrating granular and fibrillar basophilic to amphophilic bacterial colonies associated with peripheral purulent exudates (neutrophils)… Acute suppurated - Debridgement with tetracycline Failure
Sivolella et al. 2013 Case one 11,12 5 years - - - - - + …the cyst was covered with a layer of epithelium comprising three epithelial cell types, i.e., ciliated columnar(respiratory), cuboidal, and non-keratinised stratified squamous epithelium…. Implant periapical cyst - Remove cyst and GBR One failure; one success
Sukegawa et al. 2014 Case one 11 9 years + + - - - + … the cyst wall was lined with either stratified squamous epithelium or columnar epithelium. The cyst wall consisted of fibrous connective tissue, and relatively large vessels and nerves were observed… Implant periapical cyst - Remove cyst Success
Takesshita et al. 2013 Case one 21 2.5 years - + - - - + … the wall of the cystic lesion comprised of cuboidal, ciliated columnar and stratified squamous epithelium with underlying connective tissue… Implant periapical cyst - Remove cyst and apicoectomy Success
Tseng et al. 2005 Case one 45 6 months - - - - - + The curetted apical tissue was sent for pathology diagnosis, and a radicular cyst was subsequently diagnosed. Implant periapical cyst - Remove cyst Failure
Thompson-Sloan et al. 2012 Case one 11 10 years - - - - - + … revealed predominately fibrovascular connective tissue and granulation tissue… Chronic Granuloma Antibiotics-clindamycin Apicoectomy and GBR with demineralized bone matrix and collagen barrier Success
21 10 years - - - + - + Chronic suppurated-fistulized
Troiano et al. 2020 Case one 44 No report + - - + - + …the cystic wall was covered by a stratified non-keratinizing squamous epithelium …. the epithelium appeared hyperplastic, with acanthosis, vacuolization of the cheratinocytes, and focal granulocyte exocytosis. Implant periapical cyst RCT of adjacent tooth Marsupialization Success

+, present; -, absent; NRRCT, Root canal therapy; GBR, Guided bone regeneration

Histopathological assessment

Diverse pathogenesis and progression stages of IPL determine the different histopathological manifestations. In a retrospective study [35], histopathology of 37 implants revealed the intrastromal inflammatory cell infiltration, predominantly lymphocytes and plasma cells, of which 26 implants had indications of infection.

In case reports, infected granulomatous tissue was associated with generalized chronic and acute cells as well as the presence of neutrophils [13, 14, 20]. A great number of inflammatory cells, lymphocyte infiltration and necrotic tissue were observed in abscess [16, 24]. The squamous epithelium may be explored in cystic lesions, partly infiltrated by dense lymphocytes and macrophages, and partly absent from the intraepithelial lining [8, 12, 21, 23]. A case of foreign body was observed by histopathological examination with well-defined starching granules from rubber gloves [22]. Two IPL cases had undesirable bone healing and both, possessing abnormal bone formation and poor trabecular structure, were aseptic [13, 26].

Justification for proposed classification

As Table 1 shows, there is still no consensus on the classification of IPL. The included reports (70 patients/76 implants) were preliminarily distributed in Penarrocha-Diago et al. ’s classification [5]: 31 implants were inactive [8, 12, 13, 17, 18, 20, 21, 26, 27, 29, 30, 33, 36], and 46 implants were active, with acute non-suppurated(1) [13], acute suppurated (10) [6, 7, 14, 16, 19, 25, 28, 31, 32], subacute/suppurated-fistulized(7) [15, 2224, 33, 34], unclear stage(26) [35]. It should be noted that histopathological findings in some cases did not match Penarrocha-Diago et al.’s classification to some extent. For example, Nedir et al.’s [22] case presented clinical characteristics similar to the subacute/suppurated-fistulized phase, however, the detected foreign body was considered to be the culprit rather than residual infection; Cases presenting only localized pain and radiography were defined as acute suppurating [6, 7, 31], whereas histopathological evidence showed implant periapical cyst rather than inflammation; Asymptomatic cases were directly classified as inactive lesions according to the previous criteria, which led to the inclusion of cystic entity. However, the interpretation of the inactive item did not comprise cyst.

In view of the above, a more comprehensive and detailed classification was presented in Table 2 and Fig 2. Included case reports were assigned in 5 domains: acute non-suppurated (1/37), chronic granulomatous stage (5/37), acute suppurated (2/37), chronic suppurated-fistulized (6/37), implant periapical cyst (21/37), foreign body reaction (1/37), poor bone healing (2/37). The retrospective study was not involved in the above statistics due to the lack of individual case content.

Fig 2. Schematic representation of each category of histological IPL classification.

Fig 2

A: Normal implant periapical status; B: Acute non-suppurative stage (no radiological changes); C: Chronic granulomatous stage; D: Acute suppurative stage (pus formation); E: Chronic suppurative fistula (two-drainage pathways); F: Implant periapical cyst. G: Foreign body reaction (radiologically visible or invisible); H: Poor bone healing.

Class I. Implant periapical inflammation

  1. Acute non-suppurated (Fig 2B) [5]:
    • Symptoms or signs: Acute, continuous, moderate to severe and localized pain; Not aggravating the pain with percussion; Perhaps painful and inflamed periapical mucosa;
    • Histopathology: Acute inflammatory infiltrate, neutrophil infiltration
    • Radiography: No radiolucency
  2. Chronic granuloma (Fig 2C):
    • Symptoms or signs: No symptoms or light spontaneous pain; Perhaps swelled and reddish mucosa
    • Histopathology: Inflammatory granulation tissue; Increased inflammatory cells and capillaries
    • Radiography: Radiolucency

Class II. Implant periapical abscess

  1. Acute suppurated (Fig 2D) [5]:
    • Symptoms or signs: Same as the non-suppurated case
    • Histopathology: Polymorphonuclear leukocytes infiltrate and necrotic tissue
    • Radiography: Radiolucency without penetrating the bone-plate
  2. Chronic suppurated-fistulized (Fig 2E) [5]:
    • Symptoms or signs: Dull pain; Possible sinus tract around the Mucosa; A tympanic sound produced by percussion
    • Histopathology: Fibrous connective tissue hyperplasia or infiltration of lymphocytes
    • Radiography: Radiolucency with possible incomplete bone-plate

Class III. Implant periapical cyst (Fig 2F):

  • Symptoms or signs: No symptoms and possible mucosa swelling

  • Histopathology: Epithelial lining and possible cholesterol crystallization

  • Radiography: Radiolucency

Class IV. Foreign body reaction (Fig 2G):

  • Symptoms or signs: Inflammatory response or no symptoms

  • Histopathology: Foreign bodies

  • Radiography: Radiolucency or not

Class V. Poor bone healing (Fig 2H):

  • Symptoms or signs: No symptoms

  • Histopathology: Aseptic necrosis or fibrous connective tissue

  • Radiograph: Radiolucency

Treatment protocols and results

Variability of the properties did not allow the management of individual patients to be discerned, so the treatment protocols in case reports were rearranged according to the new classification format.

  1. Acute non-suppurated (1 case): by the time of intervention, the acute non-suppurative stage had progressed to the chronic granulomatous stage [13].

  2. Acute suppurated (2 cases): One case, failing to respond to antibiotics, was covered with collagen membrane after surgical debridement [25]. Tetracycline was disinfected after direct surgical debridement in another case [32]. Both implants ultimately failed to survive.

  3. Chronic granuloma (5 cases): Two cases did not respond to antibiotics and were treated with implant apicoectomy and bone graft materials [19, 33]. One case performed RCT on the adjacent teeth with the same surgical protocol as the above [13]. In the other two cases, one failed while the other one survived after implant debridement [20, 28].

  4. Chronic suppurated-fistulized (6 cases): Antibiotic treatment failed in both cases [24, 33], followed by the implant failure after surgical debridement in one case and the success with apicoectomy plus GBR in the other. One case was successfully treated with surgical debridement plus GBR and adjacent RCT [14]. The implant was not survived after surgical debridement in two cases [16], but one was reserved by implant apicoectomy [15].

  5. Implant periapical cyst (21 cases): Only the cysts were removed by surgical debridement of the 9 implants [8, 17, 23, 27, 29, 31, 36], resulting in 6 falling and 3 remaining. Apicoectomy was performed in two implants [6, 23] and marsupialization was performed in one [34]. At the end, all implants survived.

  6. Poor bone healing (2 cases): After debridement of the two implants, one implant healed well [13] while the other implant was removed because of the existing lesion [26].

In the retrospective study [35], 39 IPL were undergoing with apicoectomy. Ultimately, only 1 implant failed.

Possibility of bias

Nine papers were assessed as low possibility of bias, 13 as moderate possibility of bias, and 6 as high possibility of bias (Table 3).

Table 3. JBI critical appraisal for articles.

JBI for case reports Were patient’s demographic characteristic clearly described? Was the patient’s history clearly described and presented as a timeline? Was the current clinical condition of the patient as a presentation clearly described? Were the diagnostic tests or assessment methods and the results clearly described? Was the intervention(s) or treatment procedure(s) clearly described? Was the post-intervention clinical condition clearly described? Were the adversed events(harms) or unanticipated events identified and described? Does the case report provide takeaway lessons?
Balshi et al. 2007 Y N N N Y Y N Y
Casado et al. 2008 Y N N Y Y N Y Y
Chan et al. 2011 Y N Y N Y Y N Y
Chaffee et al. 2001 N N N Y Y Y Y Y
Dahlin et al. 2008 Y Y Y Y Y Y N Y
Favia et al. 2011 Y N N Y Y Y N N
Galzignato et al. 2010 Y Y N Y N N N Y
Kochaji et al. 2017 Y Y N Y N N N N
Kim et al. 2013 Y Y N Y N Y N Y
Manfro et al. 2018 N N N Y Y Y Y Y
Mccracken et al. 2012 N N N Y Y Y N Y
Mccrea et al. 2014 N N Y Y Y Y N Y
Nedir et al. 2007 Y N Y Y Y Y Y Y
Piattelli et al. 1995 N N N Y Y N N Y
Piattelli et al. 1998 (1) N N N N N N Y Y
Piattelli et al. 1998 (2) N N N N N N Y N
Park et al. 2004 Y Y N Y Y Y N Y
Pistilli et al. 2020 Y Y N Y Y Y N Y
Qu et al. 2013 N N Y Y Y Y Y Y
Scarano et al. 2000 N N N Y N N Y Y
Silva et al. 2010 Y N N Y N Y N Y
Sun et al. 2013 Y Y Y Y Y Y Y Y
Sivolella et al. 2013 Y Y N Y N Y N Y
Sukegawa et al. 2014 Y Y N Y Y N N Y
Takesshita et al. 2013 Y N Y Y Y Y N Y
Tseng et al. 2005 N N N Y Y N N Y
Thompson-Sloan et al. 2012 N N N Y Y Y Y Y
Troiano et al. 2020 Y Y N Y Y Y N Y
JBI for cohort study Were there clear criteria for inclusion in the case series? Was the condition measured in a standard, reliable way for all participants inluded in the case series? Were valid methods used for identification of the condition for all participants included in the case series? Did the case series have complete inclusion of participants? Was there clear reporting of clinical information of the participants? Were the outcomes or follow up results of cases clearly reported? Was there clear reporting of the presenting site(s)/clinic(s) demographic information? Was statistical analysis appropriate?
Balshi et al. 2007 Y Y Y N N Y Y Y

Discussion

Replacing the space among the missing teeth with implants is the best alternative to restore the patient’s oral morphology and function. However, complex and varied peri-implant diseases generally affect the long-term outcomes of the implant [37]. Early studies mentioned the loss of periapical supporting bone in implants, which was presumed to be related to microbial residue, bone overheating and premature loading [38, 39]. At present, IPL is considered to possess the multifactorial induction, with adjacent endodontic lesion having the highest priority [40]. Given the complexity and uncertainty of the pathogenesis, the incomplete recognition of IPL has led to the limitations of previous classification systems.

Reiser and Nevins [4] primarily divided IPL into inactive and active forms, which were also employed by Sarmast et al. [9] and Penarrocha-Diago et al [5]. Differently, the former increased the category of implant misplacement and residual infection from etiological consideration. The latter refined the characteristics of inflammatory stage from the stage of lesion progression. Regrettably, the above classifications failed to assess the histopathology of IPL, resulting in the neglection of cyst entities. Sussman et al. [41] believed that the categories "Implant to Tooth" and "Tooth to Implant" explained the potential mutual relationship between adjacent teeth and IPL. This inference was based on radiography, but it was undeniable that IPL sometimes occurred independently from the adjacent teeth. Besides, Kadkhodazadeh and Amid [11] proposed a complex classification of peri-implant disease focusing on the relationship between adjacent teeth and implant, but the interpretation of IPL was limited. Recently, Shah et al. [10] proposed a quantitative classification employing radiology to measure the affected proportion of implant. The failure to consider the pathogenesis of IPL made this classification in the need of combing with other classifications.

In this context, the proposed classification provided a comprehensive description of IPL and offered the potential to increase our knowledge and understanding of management. In Table 2, the present possible entity of IPL rather than ordinary inflammatory property was indicated, especially the histopathological evidence of cyst.

For this classification, each category has been subjected to rigorous literature screening and scholars’ evaluation while referring to Penarrocha-Diago’s proposals [5]. Within the category "implant periapical inflammation", acute non-suppurative phases were less common in the included studies. The localized pain around the implant tip aroused the attention of the implantologists, but the apical radiography could not be observed. Chan et al. [13] reported that the acute suppurative stage progressed to the chronic granuloma stage, which could be detected by apical radiograph a few days after prophylactic antibiotic administration. Apart from radiological differences, the pain response of the former was usually more severe than that of the latter, which showed granulation tissue on biopsy.

The contents of implant periapical abscess described in Penarrocha-Diago’s review [5] were confirmed by the histopathology of the included studies. The limited number of cases was due to the exclusion of previous cases focusing on radiology and ignoring histopathology. As a matter of fact, cases at this stage were often described. Pain is particularly intense during this acute suppurative stage. Without early intervention, infection can spread along the implant-bone interface, ultimately leading to the implant failure. It can also spread the facial bone-plate and form mucosal fistulas penetrated with oral cavity, allowing oral microbial infiltration. The similarity of Penarrocha-Diago’s results provides a degree of assurance with which possible histopathology was integrated.

The term "implant periapical cyst" was first mentioned and reviewed in this classification. Multiple studies reported that implant placement induced cyst formation in implant tip [6, 8, 30, 31]. As described in the case reports, the stimulation of infection or implantation might stimulate epithelial proliferation to form the cyst wall, which was composed of squamous epithelium and could be observed in tissue sections with or without inflammatory cell infiltration, depending on the origin of cyst. In general, patients with implant periapical cysts feel normal in the early stage, but the compression of enlarged cyst can cause various symptoms, such as mucosal swelling, local pain, fistula, and implant mobility. Although cysts (21/35) are the most frequently documented in Table 2, the prevalence is underestimated because some professionals may surgically remove implant periapical tissue without histopathological examination. As it can be difficult to clinically differentiate between implant periapical cyst and other IPL, the definitive diagnosis based on the histopathology study is significant.

Foreign body reaction refers to the inflammatory response caused by the presence of foreign materials at the implant tip that affects bone healing [42]. Foreign bodies, such as glove powder and metal particles from instruments, are usually brought in during the implantation. Nedir et al. [22] examined starch particles in rubber gloves in IPL that caused localized chronic granuloma or delayed hypersensitivity. Radiologically, foreign body reaction did not always present radiolucency, posing a conundrum to distinguish it from initial inflammation.

The incorporation of scar tissue, overpreparation of implant bed, and bone compression for inclusion [40] into the proposed term “poor bone healing” were considered. They are often clinically asymptomatic and radiologically confused with implant periapical cyst, therefore, aseptic, non-cystic histopathological diagnosis is critical. Hence, poor bone healing is not a disease or pathological condition in the new classification. The term is simply defined as "inactive" based on the clinically asymptomatic features and stable lesion ranges seem to require greater caution.

Cases in the literature reported that the treatment of IPL, as an empirical approach rather than the types of IPL (single or multiple), was treated by a particular technique. Treatment decision tree (Fig 3) was attempted to be reported by organizing the same category of information in the IPL. Poor bone healing with radio-only transmission was shown in Fig 2H, which has been suggested by several studies to monitor lesions without medical intervention [43]. Once the radiography increases or the patient experiences pain, surgery is required [43]. In the acute non-suppurative phase shown in Fig 2B, experimental antibiotics seem to be a reasonable conservative option to observe the progression of disease [44], although enrolled cases suggest a great possibility of failure. Reviewing the unincluded literature, it was found that systemic antibiotics for IPL included clindamycin, metronidazole, amoxicillin, cephalexin, penicillin, and cephalosporin [25, 26, 4548]. Among them, Waasdorp et al [49] and Chang et al [50] respectively used amoxicillin (500mg/d, 10d), amoxicillin (250mg/d, 3d) and acetaminophen(500mg/d, 3d), achieving a surprising success without additional management. At present, there is no consensus on the dose and type of antibiotics for IPL, and its criteria should consider etiology, symptom and open / closed lesions [50].

Fig 3. Treatment decision tree.

Fig 3

Symptoms (localized pain and puffiness) and signs (mucosal swelling and fistulas) may occur at various intensifications in different stages of infection. Foreign body reaction is shown in Fig 2G. Implant periapical radiography further confirms the need for surgical intervention [44]. Thorough debridement is identified as the centroid for the prognosis of implant, especially the plaque biofilm on the rough surface of implant [43]. Implant apicoectomy is considered to be prudent because the elevated crown/implant ratio increases the risk of unexpected mechanical complications, although it is currently considered as the most thorough and successful procedure in clinical practice (44/45). Conservative implant surface preparation has been reported, including mechanical curettage [13, 25], chemical agents [32], air-abrasive and laser decontamination [51], whereas limited case results suggest that there is no standardized prospective protocol. In this context, a phased debridement protocol was recognized, in which conservative non-resectable surgery was given priority and apicectomy was considered after ineffectiveness [40, 43]. Besides, the healing of soft tissue involved in IPL are also of concern, especially in cases of mucosa fistula.

To our knowledge, this is the first comprehensive consideration of implant periapical cyst that reduces the diagnostic complexity of different types of cysts and improves the chances of clinical use. The protocols for removing cyst are not exactly the same as the infection, with the primary privilege concentrating on the treatment of giant implant periapical cyst. While surgical excision was only discussed in the previous study, Troiano et al. [34] provided a potential solution for the successful treatment of a large implant periapical cyst with marsupialization. Biopsy during surgery is considered as a necessary element to identify recurrent cystic or malignant tumors [8, 17]. Obviously, this effectively reduces the risk of complications such as implant mobility and fracture caused by direct debridement, thus resulting in large scale of bone defects.

In conclusion, this report, presenting a general classification framework that can highlight the complexity of IPL, is suitable for integrating into the clinical practice. We have done preliminary verification with limited evidence. However, additional cohort studies containing histopathological evidence are necessary to complement and refine the applicability and comprehensiveness of the new classification. This classification is timely for IPL although the ointment is the inability to verify the optimal treatment protocols.

Supporting information

S1 File

(ZIP)

Acknowledgments

Authors are thankful for Dr. Wang and Dr. Dai to help with the literature screening and quality assessment.

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

Our research was supported by the Natural Science Foundation of Gansu Province (20JR10RA006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Buser D, Sennerby L, De Bruyn H. Modern implant dentistry based on osseointegration: 50 years of progress, current trends and open questions. Periodontology 2000. 2017;73(1):7–21. 10.1111/prd.12185 [DOI] [PubMed] [Google Scholar]
  • 2.McAllister BS, Masters D, Meffert RM. Treatment of implants demonstrating periapical radiolucencies. Practical periodontics and aesthetic dentistry: PPAD. 1992;4(9):37–41 [PubMed] [Google Scholar]
  • 3.Schwarz F, Derks J, Monje A, Wang HL. Peri-implantitis. Journal of clinical periodontology. 2018;45 Suppl 20:S246–s66. 10.1111/jcpe.12954 [DOI] [PubMed] [Google Scholar]
  • 4.Reiser GM, Nevins M. The implant periapical lesion: etiology, prevention, and treatment. Compendium of continuing education in dentistry (Jamesburg, NJ: 1995). 1995;16(8):768, 70, 72 passim [PubMed] [Google Scholar]
  • 5.Peñarrocha Diago M, Boronat López A, Lamas Pelayo J. Update in dental implant periapical surgery. Medicina oral, patologia oral y cirugia bucal. 2006;11(5):E429–32 [PubMed] [Google Scholar]
  • 6.Takeshita K, Funaki K, Jimbo R, Takahashi T. Nasopalatine duct cyst developed in association with dental implant treatment: A case report and histopathological observation. Journal of oral and maxillofacial pathology: JOMFP. 2013;17(2):319. 10.4103/0973-029x.119761 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Pistilli R, Canullo L, Menini M, Pistilli V, Rossi-Fedele G, Pesce P. Retrograde peri-implantitis associated with residual cysts: 3 Case reports. Journal of the American Dental Association (1939). 2020;151(12):956–61. 10.1016/j.adaj.2020.07.016 [DOI] [PubMed] [Google Scholar]
  • 8.Kochaji N. Inflammatory odontogenic cyst on an osseointegrated implant: A peri-implant cyst? New entity proposed. Dental & Medical Problems. 2017;54(3):303–6. [Google Scholar]
  • 9.Sarmast ND, Wang HH, Soldatos NK, Angelov N, Dorn S, Yukna R, et al. A Novel Treatment Decision Tree and Literature Review of Retrograde Peri-Implantitis. Journal of periodontology. 2016;87(12):1458–67. 10.1902/jop.2016.160219 [DOI] [PubMed] [Google Scholar]
  • 10.Shah R, Thomas R, Kumar AB, Mehta DS. A Radiographic Classification for Retrograde Peri-implantitis. The journal of contemporary dental practice. 2016;17(4):313–21. 10.5005/jp-journals-10024-1847 [DOI] [PubMed] [Google Scholar]
  • 11.Kadkhodazadeh M, Amid R. A New Classification for the Relationship between Periodontal, Periapical, and Peri-implant Complications. Iranian endodontic journal. 2013;8(3):103–8. [PMC free article] [PubMed] [Google Scholar]
  • 12.Casado PL, Donner M, Pascarelli B, Derocy C, Duarte ME, Barboza EP. Immediate dental implant failure associated with nasopalatine duct cyst. Implant dentistry. 2008;17(2):169–75. 10.1097/ID.0b013e3181776c52 [DOI] [PubMed] [Google Scholar]
  • 13.Chan HL, Wang HL, Bashutski JD, Edwards PC, Fu JH, Oh TJ. Retrograde peri-implantitis: a case report introducing an approach to its management. Journal of periodontology. 2011;82(7):1080–8. 10.1902/jop.2010.100585 [DOI] [PubMed] [Google Scholar]
  • 14.Chaffee NR, Lowden K, Tiffee JC, Cooper LF. Periapical abscess formation and resolution adjacent to dental implants: a clinical report. The Journal of prosthetic dentistry. 2001;85(2):109–12. 10.1067/mpr.2001.113353 [DOI] [PubMed] [Google Scholar]
  • 15.Dahlin C, Nikfarid H, Alsén B, Kashani H. Apical peri-implantitis: possible predisposing factors, case reports, and surgical treatment suggestions. Clinical implant dentistry and related research. 2009;11(3):222–7. 10.1111/j.1708-8208.2008.00108.x [DOI] [PubMed] [Google Scholar]
  • 16.Favia G, Piattelli A, Sportelli P, Capodiferro S, Iezzi G. Osteonecrosis of the posterior mandible after implant insertion: a clinical and histological case report. Clinical implant dentistry and related research. 2011;13(1):58–63. 10.1111/j.1708-8208.2009.00181.x [DOI] [PubMed] [Google Scholar]
  • 17.Galzignato PF, Sivolella S, Cavallin G, Ferronato G. Dental implant failure associated with a residual maxillary cyst. British dental journal. 2010;208(4):153–4. 10.1038/sj.bdj.2010.156 [DOI] [PubMed] [Google Scholar]
  • 18.Kim JJ, Freire M, Yoon JH, Kim HK. Postoperative maxillary cyst after maxillary sinus augmentation. The Journal of craniofacial surgery. 2013;24(5):e521–3. 10.1097/SCS.0b013e3182a238a4 [DOI] [PubMed] [Google Scholar]
  • 19.Manfro R, Garcia GF, Bortoluzzi MC, Fabris V, Bacchi A, Elias CN. Apicoectomy and Scanning Electron Microscopy Analysis of an Implant Infected by Apical (Retrograde) Peri-implantitis: A Case Letter. The Journal of oral implantology. 2018;44(4):287–91. 10.1563/aaid-joi-D-16-00162 [DOI] [PubMed] [Google Scholar]
  • 20.McCracken MS, Chavali RV, Al-Naief NS, Eleazer PD. A residual granuloma in association with a dental implant. Implant dentistry. 2012;21(2):87–90. 10.1097/ID.0b013e31824c2b52 [DOI] [PubMed] [Google Scholar]
  • 21.McCrea SJ. Nasopalatine duct cyst, a delayed complication to successful dental implant placement: diagnosis and surgical management. The Journal of oral implantology. 2014;40(2):189–95. 10.1563/aaid-joi-d-12-00011 [DOI] [PubMed] [Google Scholar]
  • 22.Nedir R, Bischof M, Pujol O, Houriet R, Samson J, Lombardi T. Starch-induced implant periapical lesion: a case report. The International journal of oral & maxillofacial implants. 2007;22(6):1001–6. [PubMed] [Google Scholar]
  • 23.Park WB, Kim YJ, Han JY, Kang P. Successful Management of Dental Implants in Postoperative Maxillary Cyst: A Case Report With a 13-Year Follow-Up. The Journal of oral implantology. 2020;46(2):133–8. 10.1563/aaid-joi-D-19-00191 [DOI] [PubMed] [Google Scholar]
  • 24.Piattelli A, Scarano A, Balleri P, Favero GA. Clinical and histologic evaluation of an active "implant periapical lesion": a case report. The International journal of oral & maxillofacial implants. 1998;13(5):713–6 [PubMed] [Google Scholar]
  • 25.Piattelli A, Scarano A, Piattelli M. Abscess formation around the apex of a maxillary root form implant: clinical and microscopical aspects. A case report. Journal of periodontology. 1995;66(10):899–903. 10.1902/jop.1995.66.10.899 [DOI] [PubMed] [Google Scholar]
  • 26.Piattelli A, Scarano A, Piattelli M, Podda G. Implant periapical lesions: clinical, histologic, and histochemical aspects. A case report. The International journal of periodontics & restorative dentistry. 1998;18(2):181–7 [PubMed] [Google Scholar]
  • 27.Qu C, Meng H, Han J. Implant periapical lesion—a review and a case report with histological evaluation. Clinical oral implants research. 2014;25(9):1099–104. 10.1111/clr.12232 [DOI] [PubMed] [Google Scholar]
  • 28.Scarano A, Di Domizio P, Petrone G, Iezzi G, Piattelli A. Implant periapical lesion: a clinical and histologic case report. The Journal of oral implantology. 2000;26(2):109–13. [DOI] [PubMed] [Google Scholar]
  • 29.Silva GC, Oliveira DR, Vieira TC, Magalhães CS, Moreira AN. Unusual presentation of active implant periapical lesions: a report of two cases. Journal of oral science. 2010;52(3):491–4. 10.2334/josnusd.52.491 [DOI] [PubMed] [Google Scholar]
  • 30.Sivolella S, Valente M, Gasparini E, Stellini E. Nasopalatine duct cyst as a complication of dental implant placement: a case report. Minerva stomatologica. 2013;62(6):235–9 [PubMed] [Google Scholar]
  • 31.Sukegawa S, Kanno T, Kawai H, Takebe Y, Shibata A, Takahashi Y, et al. Nasopalatine duct cyst associated with dental implant treatment: A case report. Oral and Maxillofacial Surgery Cases. 2015;1(3):38–41. [Google Scholar]
  • 32.Sun CX, Henkin JM, Ririe C, Javadi E. Implant failure associated with actinomycosis in a medically compromised patient. The Journal of oral implantology. 2013;39(2):206–9. 10.1563/aaid-joi-d-11-00028 [DOI] [PubMed] [Google Scholar]
  • 33.Thompson-Sloan TN, Kolhatkar S, Bhola M. Management of Retrograde Peri-Implantitis by Apical Resection and Guided Bone Regeneration in Adjacent Maxillary Implants. Clinical Advances in Periodontics. 2012;2(4):250–5. 10.1902/cap.2012.110106 [DOI] [Google Scholar]
  • 34.Troiano A, Lo Giudice G, De Luca R, Lo Giudice F, D’Amato S, Tartaro G, et al. Salvage of Dental Implant Located in Mandibular Odontogenic Cyst. A Conservative Surgical Treatment Proposal. Dentistry journal. 2020;8(2). 10.3390/dj8020049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Balshi SF, Wolfinger GJ, Balshi TJ. A retrospective evaluation of a treatment protocol for dental implant periapical lesions: long-term results of 39 implant apicoectomies. The International journal of oral & maxillofacial implants. 2007;22(2):267–72 [PubMed] [Google Scholar]
  • 36.Tseng CC, Chen YH, Pang IC, Weber HP. Peri-implant pathology caused by periapical lesion of an adjacent natural tooth: a case report. The International journal of oral & maxillofacial implants. 2005;20(4):632–5 [PubMed] [Google Scholar]
  • 37.Tonetti MS, Chapple IL, Jepsen S, Sanz M. Primary and secondary prevention of periodontal and peri-implant diseases: Introduction to, and objectives of the 11th European Workshop on Periodontology consensus conference. J Clin Periodontol. 2015;42 Suppl 16:S1–4. doi: 10.1111/jcpe.12382 [DOI] [PubMed] [Google Scholar]
  • 38.Bretz WA, Matuck AN, de Oliveira G, Moretti AJ, Bretz WA. Treatment of retrograde peri-implantitis: clinical report. Implant Dent. 1997;6(4):287–90. 10.1097/00008505-199700640-00004 [DOI] [PubMed] [Google Scholar]
  • 39.Sussman HI. Implant pathology associated with loss of periapical seal of adjacent tooth: clinical report. Implant Dent. 1997;6(1):33–7. 10.1097/00008505-199700610-00007 [DOI] [PubMed] [Google Scholar]
  • 40.Temmerman A, Lefever D, Teughels W, Balshi TJ, Balshi SF, Quirynen M. Etiology and treatment of periapical lesions around dental implants. Periodontology 2000. 2014;66(1):247–54. 10.1111/prd.12055 [DOI] [PubMed] [Google Scholar]
  • 41.Sussman HI. Periapical implant pathology. The Journal of oral implantology. 1998;24(3):133–8. [DOI] [PubMed] [Google Scholar]
  • 42.Albrektsson T, Dahlin C, Jemt T, Sennerby L, Turri A, Wennerberg A. Is marginal bone loss around oral implants the result of a provoked foreign body reaction? Clinical implant dentistry and related research. 2014;16(2):155–65. 10.1111/cid.12142 [DOI] [PubMed] [Google Scholar]
  • 43.Peñarrocha-Diago M, Peñarrocha-Diago M, Blaya-Tárraga JA. State of the art and clinical recommendations in periapical implant lesions. 9th Mozo-Grau Ticare Conference in Quintanilla, Spain. Journal of clinical and experimental dentistry. 2017;9(3):e471–e3. 10.4317/jced.53600 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Peñarrocha-Diago M, Maestre-Ferrín L, Cervera-Ballester J, Peñarrocha-Oltra D. Implant periapical lesion: diagnosis and treatment. Medicina oral, patologia oral y cirugia bucal. 2012;17(6):e1023–7. 10.4317/medoral.17996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Brisman DL, Brisman AS, Moses MS. Implant failures associated with asymptomatic endodontically treated teeth. Journal of the American Dental Association (1939). 2001;132(2):191–5. 10.14219/jada.archive.2001.0154 [DOI] [PubMed] [Google Scholar]
  • 46.Park SH, Sorensen WP, Wang HL. Management and prevention of retrograde peri-implant infection from retained root tips: two case reports. The International journal of periodontics & restorative dentistry. 2004;24(5):422–33. 10.11607/prd.00.0604 [DOI] [PubMed] [Google Scholar]
  • 47.Quirynen M, Gijbels F, Jacobs R. An infected jawbone site compromising successful osseointegration. Periodontology 2000. 2003;33:129–44. 10.1046/j.0906-6713.2002.03311.x [DOI] [PubMed] [Google Scholar]
  • 48.Rokadiya S, Malden NJ. An implant periapical lesion leading to acute osteomyelitis with isolation of Staphylococcus aureus. British dental journal. 2008;205(9):489–91. 10.1038/sj.bdj.2008.935 [DOI] [PubMed] [Google Scholar]
  • 49.Waasdorp J, Reynolds M. Nonsurgical treatment of retrograde peri-implantitis: a case report. The International journal of oral & maxillofacial implants. 2010;25(4):831–3 [PubMed] [Google Scholar]
  • 50.Chang LC, Hsu CS, Lee YL. Successful medical treatment of an implant periapical lesion: a case report. Chang Gung medical journal. 2011;34(1):109–14 [PubMed] [Google Scholar]
  • 51.Soldatos N, Romanos GE, Michaiel M, Sajadi A, Angelov N, Weltman R. Management of Retrograde Peri-Implantitis Using an Air-Abrasive Device, Er, Cr: YSGG Laser, and Guided Bone Regeneration. Case reports in dentistry. 2018;2018:7283240. 10.1155/2018/7283240 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Fahad Umer

21 Nov 2022

PONE-D-22-29419A Novel Histopathological Classification of Implant Periapical Lesion: A Systematic Review and Treatment Decision TreePLOS ONE

Dear Dr. Mei Mei

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Please review  the comments carefully and do appropriate corrections as advised by the  peers.

==============================

Please submit your revised manuscript by 05 January 2023. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Fahad Umer

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1.  Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please ensure that you include the complete search strategy in your manuscript, or as a Supplementary Information file, such that it could be repeated.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

6. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“This study was supported by the following funding:

The Natural Science Foundation of Gansu Province (20JR10RA006)”

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

7. Please include a separate caption for each figure in your manuscript.

8. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files.

9. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The concept of this systematic review is clinically applicable and will add to the literature to improve our understanding of the implant periapical lesions.

There are few areas that need clarification.

1. Why was this review not registered at Prospero ?

2. Proper analysis method was not adapted using PICO.

3. Since antibiotics didn't play a strong role in resolution of the lesion, then why was it still advocated in the treatment decision tree ?

4. In case of the antibiotics usage, what was the dosage and type recommended ?

5. Were all the included patients healthy ?

Reviewer #2: Overall its an interesting systematic review.

In proposed classification and management, the Author did not take into account soft tissue changes. for example fig 2e could propose soft tissue challenges.

It is a systematic review therefore statistical analysis is not applicable.

Minor typing and grammatical errors.

In result, you did not report the quality you assign to each study. Either summarised in the results section or as an extra column in your study characteristics table.

Most of the studies have one or two cases therefore any management recommendation should be advised cautiously.

Any recommendation on antibiotics protocols, such as before or after procedure, and what antibiotics to be considered?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 22;17(12):e0277387. doi: 10.1371/journal.pone.0277387.r002

Author response to Decision Letter 0


5 Dec 2022

Dear editor and reviewers:

We sincerely thank the editors and reviewers for their careful review and detailed suggestions on this manuscript, which undoubtedly enriches the article. The following is our reply to the revision of the article, and the revised parts are underlined in the manuscript:

Response to editor Fahad Umer:

1. Please ensure that your manuscript meets PLOS ONE's style requirements

Answer: We apologize for the nonstandard format of our manuscript. Through the link you provided, we have made modifications according to the requirements, including abstract, font size, references, title, etc. We hope this modification can meet the requirements of the journal. Please contact us in time if anything is still not suitable.

2. Please ensure that you include the complete search strategy in your manuscript, or as a Supplementary Information file, such that it could be repeated.

Answer: We sincerely acknowledge that this was an oversight on our part. We have uploaded the search strategy as supplementary material. In order to obtain as much IPL related literature as possible, we mainly searched a variety of terms of IPL, and at the same time added the citation search of key literature. In this way, the relevant literature can be collected as comprehensively as possible.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

Answer: We apologize for our oversight. We have rechecked the fund information, and the conclusion is that the fund name and number are correct.

4. Data Availability statement

Answer: Yes. We are not going to change the data availability statement. Thank you very much!

5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016.

Answer: We appreciate your suggestion. As the corresponding author, I applied for a new ORCID with ID 0000-0003-1948-2620. If you need more information, please contact us.

6. We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript.

Answer: We apologize for our non-standard format. We have removed this part from the revised manuscript. In the acknowledgments section, we express our gratitude to the professionals in literature screening and data extraction, and we express the non-relevance statement in the cover letter. Finally, thank you for your help in correcting our flaws in the online submission form.

7. Please include a separate caption for each figure in your manuscript.

Answer: We appreciate your suggestions. We have made modifications according to the requirements of the journal and hope to meet the requirements.

8. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files.

Answer: We appreciate the editor's suggestion. We have uploaded the additional materials as supplementary materials.

9. Please review your reference list to ensure that it is complete and correct.

Answer: We appreciate the editor's suggestion. According to the requirements of the journal, we modified the format of the references and checked the information of the references, hoping to meet the requirements of the journal

Response to reviewer#1:

1. Why was this review not registered at Prospero ?

Answer: We really appreciate your proposal. Without registration PROSPERO, we have two main considerations that we hope you can understand: First, our study relies on literature review to propose a new classification. Throughout the process, we focused on classification and treatment decision trees. Second, we used electronic and manual retrieval methods. The simple search strategy was designed to collect as much literature as possible on IPL, which may not be suited to PROSPERO's protocol. Therefore, we did not initially register with PROSPERO. But there is no denying that the evidence would be better if pre-registered with PROSPERO. We apologize for neglecting PROSPERO's registration by focusing on the design of the new classification and treatment decision tree. To complete this research, we have supplemented the PROSPERO registration (CRD42022378001).We hope it will not affect the quality and innovation of our study.

2. Proper analysis method was not adapted using PICO.

Answer: We thank the reviewers for pointing out this problem. We initially focused on the histological characteristics of IPL and did not describe the PICO standards in detail, which may have led to the misunderstanding of the reviewers. We have now re-modified the PICO. However, the reports of IPL are cohort studies or case reports, and there is no control group, so we cannot describe the part of “C”.

3. Since antibiotics didn't play a strong role in resolution of the lesion, then why was it still advocated in the treatment decision tree ?

Answer: This problem raised by the reviewer is caused by our insufficient expression. We sincerely apologize for it. In the discussion section, we mentioned that antibiotics could be tried, but did not point out the source of our opinion. In fact, our review of the literature found that a small number of scholars reported cases of IPL being cured with antibiotics alone (amoxicillin or amoxicillin and acetaminophen). However, their reports did not involve histopathology, which made it difficult to determine their category and therefore they did not meet our inclusion criteria. We have made a detailed elaboration of this situation in the paper, hoping that this will not affect readers' reading.

4. In case of the antibiotics usage, what was the dosage and type recommended ?

Answer: We thank the reviewer for pointing out this part. Since many studies have failed to completely cure IPL by using antibiotics alone, some scholars have still achieved success. By reviewing the limited evidence, we found that they were inconsistent in dose and type, depending on the surgeon's experience and the characteristics of the IPL. There is no consensus or guidelines, but it is important to note that antibiotic use should be measured according to the cause, symptoms, or opening/closing of IPL. In addition, although antibiotics alone failed in some cases, reducing the discomfort of patients, and limiting the progression of the disease in stages was also mentioned as an advantage. Therefore, we add these views in the discussion section, hoping to be helpful to the paper (Page 21).

5. Were all the included patients healthy ?

We thank the reviewer for pointing out this aspect. Since most of the included studies were case reports, individual differences (age, sex, implant type) were difficult to regulate, which is different from the criteria for participants in cohort studies. In order not to affect the results of the study, we re-reviewed the included 28 articles and found that all participants did not have systemic diseases that induced IPL. In the interest of gathering the histological features of IPL as much as possible, we have not restricted the condition of participants (no systemic disease).

Response to reviewer#2:

1. In proposed classification and management, the Author did not take into account soft tissue changes. for example fig 2e could propose soft tissue challenges.

Answer: We would like to thank the reviewer for his valuable questions on soft tissue management, which is a deficiency that does exist in our manuscript. In our classification, mucosal swelling and fistulas are described in Classification 2. Correspondingly, we did not cover the management of soft tissue in the discussion. We have to admit that the management of soft tissue is very important for peri-implant health. However, in none of the studies we included which the authors provide detailed evidence for managing soft tissue. This makes it impossible to describe IPL's soft tissue management protocols clearly. But as a rule of thumb, soft tissue abnormalities generally recover with the removal of the lesion, which may be a reason they were not described in the study. Based on the available evidence, we were careful in our discussion part to recommend the importance of soft tissue healing and need to maintain close attention (Page22. Adding: Besides, the healing of soft tissue involved in IPL are also of concern, especially in cases of mucosa fistula.). We hope this answer can be supported by the reviewers.

2. It is a systematic review therefore statistical analysis is not applicable.

Answer: We thank the reviewers for the suggestion. Since this study is a re-enumeration of previous studies, we did miss this point. Therefore, we modified "data synthesis" to "information synthesis", which is more consistent with the system evaluation. In addition, we have simplified the content for readers to understand.

3. Minor typing and grammatical errors.

Answer: We apologize for some language and grammatical errors in our manuscript. We spent a lot of time on the manuscript, and additions and deletions may have contributed to the problem. We have now made further changes to the language and grammar, and have had a professional English scholar to proofread it. We hope this manuscript has been improved.

4. In result, you did not report the quality you assign to each study. Either summarised in the results section or as an extra column in your study characteristics table.

Answer: We apologize for the irregular chart arrangement of the first draft which made it difficult for reviewers to read. NOS was used to assess the quality of the included case reports and cohort studies, and the results are listed in Table 3. I hope the layout of this time will not affect the reviewer's reading.

5. Most of the studies have one or two cases therefore any management recommendation should be advised cautiously.

Answer: We sincerely thank the reviewers for their suggestions. We reviewed the discussion section of the manuscript to make it as referential and objective as possible.

6. Any recommendation on antibiotics protocols, such as before or after procedure, and what antibiotics to be considered?

Answer: We sincerely admit that we did not describe the use of antibiotics in detail, and thank the reviewer for pointing out this problem. In fact, in the discussion section, we briefly mentioned antibiotics and suggested trying them in Category 1. The reason for this is that we found several studies in the literature we reviewed (where no histological evidence was excluded) that completely cured IPL with antibiotics alone. Among them, they use different antibiotics and dosages, which makes the available evidence not a reasonable guide or recommendation. In this case, we added the key elements mentioned above to the discussion and recommended the use of antibiotics (e.g. Metronidazole, amoxicillin) according to the cause, symptoms and signs of IPL.

The above is my reply to editors and reviewers. If you have any questions, please contact me in time. Sincerely thank you for your suggestions to make our study better!

Best regards!

Yours sincerely,

Dr. Mei Mei

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Fahad Umer

7 Dec 2022

A novel histopathological classification of implant periapical lesion: a systematic review and treatment decision tree

PONE-D-22-29419R1

Dear Dr.Mei Mei,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Fahad Umer

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Fahad Umer

13 Dec 2022

PONE-D-22-29419R1

A novel histopathological classification of implant periapical lesion: a systematic review and treatment decision tree

Dear Dr. Mei:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Fahad Umer

Academic Editor

PLOS ONE


Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES